The global stereotactic surgery devices market size is estimated to be approximately USD 28.62 billion in 2025 and USD 38.03 billion in 2032, growing at a CAGR of 4.2% from 2025 to 2032.
Get Complete Analysis Of The Report - Download Free Sample PDF
Stereotactic surgery is a minimally invasive technique that employs a three-dimensional coordinate system to precisely locate and target small structures within the body, such as deep brain areas or tumors, for procedures like biopsies, electrode placement, or focused radiation therapy. This approach integrates advanced imaging, patient immobilization, and specialized instruments to accurately guide surgical tools or radiation beams, thereby minimizing damage to surrounding healthy tissues and enhancing treatment precision.
The key drivers of the stereotactic surgery devices market include the rising prevalence of neurological disorders and cancers, which increase demand for precise, minimally invasive surgical procedures. Additionally, continuous technological advancements, such as AI integration and improved imaging systems, along with growing healthcare investments and government support, are accelerating market growth globally.
Key trends in the stereotactic surgery devices market include the increasing integration of robotics and artificial intelligence to enhance surgical precision and consistency. There is a growing demand for minimally invasive treatments driven by the rising prevalence of neurological disorders, which promotes the use of advanced, image-guided technologies such as MRI, CT, Image-Guided Radiation Therapy (IGRT), and stereotactic radiosurgery (SRS) to improve targeting accuracy and safety.
The market is also shifting toward more sophisticated and integrated systems that support a broader range of clinical applications, including treatment of brain tumors and epilepsy, emphasizing safer, more effective, and increasingly autonomous surgical solutions. These advancements aim to maximize procedure effectiveness while minimizing human limitations and patient recovery time.
Segmentation:
The global stereotactic surgery devices market is segmented by Product Type (Stereotactic Systems, Gamma Knife, Linear Accelerators (LINAC), Proton Beam Therapy Systems, and Accessories), Application (Brain Tumor Treatment, Functional Disorders, Other Applications), Technology (Frame-based Stereotactic Systems, Frameless Stereotactic Systems, and Robotic-assisted Systems), End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report provides the value (in USD million) for the above segments.
For Detailed Market Segmentation - Get a Free Sample PDF
Market Drivers:
The stereotactic surgery devices market is primarily driven by the rising global prevalence of neurological disorders and cancers. Neurological conditions, such as epilepsy and Parkinson's disease, which affect a significant portion of the population, have fueled the demand for advanced, precise surgical interventions. In April 2025 an article published in the Journal of Clinical Medicine, reported epilepsy affecting 1% and Parkinson’s 0.4% of the global population. Similarly, another article published in February 2025 in the journal BMC Health reported that 443 million disability-adjusted life-years (DALYs) from neurological diseases impacting 3.4 billion people. This burden, exacerbated by aging populations especially in Asia, fuels demand for precise, minimally invasive treatments.
The stereotactic radiosurgery (SRS) market is driven by growing efforts to improve access and training, especially in underserved regions. In June 2024, Apollo Cancer Centres, in partnership with Accuray, launched India’s first Robotic & Stereotactic Radiosurgery education program at Chennai and Bangalore. This initiative offers advanced hands-on training to radiation oncologists and therapists across India and the sub-continent, enhancing local expertise in cutting-edge radiosurgery like CyberKnife technology. Despite SRS’s proven safety and effectiveness in treating brain tumors, vascular malformations, and disorders like trigeminal neuralgia, significant global disparities in access remain. By providing comprehensive training to radiation oncologists, physicists, and technologists, this program aims to equip healthcare professionals with the necessary expertise to leverage cutting-edge SRS technologies, ultimately improving patient access to these life-changing treatments, especially in underserved regions, thereby fuelling the growth of this market.
Market Restraints:
The growth of the stereotactic surgery devices market is being held back by real-world accuracy and safety issues. Even advanced equipment can have small but important errors at every step—from taking brain scans to positioning the device. Studies testing over 21,500 measurements found that factors like the weight of the device on the patient’s head, reattaching guides, or using calibration tools can all add up to reduce precision. These aren’t just numbers; they mean a surgeon might not hit the exact spot they need to, which can affect how well the treatment works and patient safety. This makes hospitals and surgeons cautious about adopting these systems widely.
The stereotactic surgery devices market is likely to generate meaningful social and economic benefits through improved patient outcomes, shorter hospital stays, faster recovery, and reduced long-term disability for conditions like brain tumors, epilepsy, and movement disorders, enabling patients to return to work sooner and decreasing caregiver burdens. This growth also spurs high-skill job creation in surgery, medical physics, engineering, and maintenance, fostering innovation ecosystems and local manufacturing and service industries. Yet high upfront costs, specialized training, and regulatory barriers may widen access gaps between rich and resource-limited regions unless supported by favorable reimbursement, public–private partnerships, and scalable platforms. As robotics and AI mature, policy, standardization, and data security will be crucial to ensuring equitable, safe adoption, maximizing societal value while managing cost and equity considerations.
COVID-19 initially reduced elective stereotactic procedures and disrupted supply chains, slowing adoption of robotic SRS; however, hospitals improved safety, used telemedicine, and prioritized urgent cases, helping the market recover. Global wars can disrupt shipments and funding for medical devices, yet resilience comes from diversified suppliers, regional production, and international collaboration to maintain access to life-saving stereotactic technologies.
Segmental Analysis
The growth of stereotactic systems is propelled by their ability to provide highly precise, minimally invasive navigation and treatment across various medical procedures, from neurosurgery to treating brain metastases and other conditions. Advanced platforms like the ZAP-X, alongside established systems like CyberKnife and Gamma Knife, are key drivers. These systems offer enhanced accuracy, improved dose distribution, and better protection of surrounding healthy tissue, particularly in complex applications like treating brain metastases. Moreover the continuous technological upgrades and the increasing demand for accurate targeting in biopsies, tumor removals, and functional neurosurgery are further fueling the adoption and expansion of stereotactic systems.
Brain Tumour segment is expected to witness significant growth over the forecast period, as stereotactic surgery devices like Gamma Knife and CyberKnife use noninvasive, highly accurate radiation to target tumors, minimizing damage to healthy brain tissue. In 2025, Brain tumour Society published a research highlighting 3,920 new cases of primary childhood brain tumors are expected to be diagnosed in 2023. The source also reported that brain tumours are the second most common cancer overall in individuals ages 15-39 and 81.7% of all primary brain tumors occur in the adult population. Thus, the burden of brain tumors in India is staggering, which is increasing the usage of specialized stereotactic systems. Also the availability and continued advancement of these specialized stereotactic systems are crucial in addressing the significant brain tumor burden across world and improving patient outcomes.
Frame-based stereotactic systems are still widely used for highly precise brain targeting in radiosurgery, biopsy, and functional neurosurgery, with skull-anchored frames from brands like Leksell, Brown–Roberts–Wells, Cosman–Roberts–Wells, and Kelly–Goerss guiding submillimeter accuracy through CT/MRI-based planning and coordinate transfer. They underpin traditional Gamma Knife workflows and certain invasive diagnostic procedures, offering exceptional stability and reproducibility across multi-session treatments, albeit at the cost of patient comfort and a more involved setup. While the market is gradually shifting toward frameless, robotic, and image-guided solutions, frame-based systems remain relevant in many centers due to regulatory familiarity and existing infrastructure.
Hospitals are increasingly turning to advanced stereotactic systems to provide more precise and less invasive treatment options for patients with brain tumors and other neurological conditions. Tools like the Gamma Knife and CyberKnife allow doctors to deliver highly focused radiation with remarkable accuracy, minimizing damage to surrounding healthy tissue. Moreover, the growing elderly population and increasing incidence of neurological disorders further boost demand. As a result, hospitals have become central hubs for deploying these cutting-edge technologies, improving outcomes and optimizing healthcare resources.
Also, robotic systems are also gaining traction for their ability to assist in complex procedures with enhanced control and consistency. This shift not only improves patient outcomes and shortens recovery times but also helps hospitals stay at the forefront of medical innovation, offering cutting-edge care that meets growing patient and physician expectations.
North America dominates the stereotactic surgery market, driven by rising cancer rates linked to lifestyle factors, significant technological progress, and government support for early detection and treatment, exemplified by grants for cancer research centers. Breast cancer, the most common cancer among American women, contributing around 30% of new diagnoses and 12.5% globally, represents a major area where stereotactic systems are crucial. This high prevalence, coupled with regional advancements and awareness campaigns, fuels the demand for precise stereotactic interventions in North America.
Moreover, the arrival of international entrants and their advanced devices in North America is likely to spur market growth by expanding provider options, intensifying competition, and accelerating adoption of robotic stereotactic technologies. For instance, in July 2025, Koh Young Technology Inc. installed its brain surgery robot, Geniant Cranial, in a U.S. hospital, marking its first overseas deployment after nine years of development. This installation represented a significant entry into the North American stereotactic surgery market. The introduction of this advanced robotic system, known for its precision in neurosurgery, suggested a potential shift towards more sophisticated and potentially less invasive surgical options in the region, offering a new tool for complex brain procedures and contributing to the market's ongoing technological evolution.
To Learn More About This Report - Request a Free Sample Copy
The competitive landscape of the stereotactic surgery market is characterized by a dynamic interplay between established players and emerging innovators. Companies like Elekta (Gamma Knife), Accuray (CyberKnife), and Medtronic (Mazor Robotics) represent significant forces, offering a range of frame-based, frameless, and robotic systems. However, the market is increasingly shaped by new entrants and technological advancements, such as Koh Young Technology's robotic system, which introduce novel approaches and enhance existing capabilities. This competition is driving innovation in areas like robotic assistance, AI-powered planning, and improved imaging integration, all aimed at enhancing precision, minimizing invasiveness, and improving patient outcomes, thereby creating a more robust and rapidly evolving market.
The following are companies that are providing services in this market:
Recent Developments:
Q1. What the main growth driving factors for this market?
The main growth drivers include technological innovations in imaging and robotics, rising neurological disorders like brain tumors, and increasing demand for minimally invasive, precise surgeries
Q2. What are the main restraining factors for this market?
Key restraints are stringent regulatory requirements, high costs of stereotactic systems, shortage of skilled professionals, and limited insurance reimbursements for certain procedures, slowing market adoption.
Q3. Which segment is expected to witness high growth?
The frameless stereotactic systems segment is expected to witness high growth due to better patient comfort, improved accuracy, and growing preference in hospitals and neurosurgery centers.
Q4. Who are the top major players for this market?
Major players dominating the market include Medtronic, Elekta, Accuray, Varian Medical Systems, Siemens Healthineers, Brainlab, CIRS, and Raysearch Laboratories.
Q5. Which country is the largest player?
North America is the largest market, holding the highest share due to advanced healthcare infrastructure, high cancer incidence, strong government initiatives, and technological leadership.
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
